Published:
Category: Group updates

Canada Day Weekend Closures – July 1 (Canada Day) & July 4 (Queen’s Holiday)

The CCTG Central Offices will be closed on Friday, July 1st for Canada Day and will have limited staff covering critical activities on Monday, July 4th for a Queen’s University holiday. Regular business hours will resume on Tuesday, July 5th at 8:30 am EST. All web-based applications will be available.

Shipment of Specimens for Banking + Kit Supply

Read More

Published:
Category: News

It was recently announced that ExCELLirate Canada has successfully been granted a Research Infrastructure award of $4,159,049 by the Ontario Research Fund for the Innovation Fund Project Grant "ExCELLirate Canada: Expanding CELL-based Immunotherapy Research Acceleration for Translation and Evaluation".

Read More

Published:
Category: News
Expansion of the Tissue Bank facilities
The recently launched Centre for Health Innovation (CHI), a partnership with Queen’s University and Kingston Health Sciences Centre (KHSC), aims to connect researchers from across multiple disciplines to tackle the most pressing human health challenges. A critical part of the centre will be a new home for the CCTG Tumour Tissue Data Repository (TTDR) and includes a large-scale expansion of its histopathology and biobanking resources. The expansion of the TTDR will enhance the current capacity for several ongoing and new CCTG initiatives: Precision Medicine Platforms, Cellular Therapy, and Immunotherapy. CCTG’s infrastructure investment includes a larger centralized capacity for genomic, transcriptomic and proteomic studies that will leverage expertise among member sites. Read More

Published:
Category: News
Solving Cancer Together Strategic Plan 2022-2027

Following a comprehensive, year-long consultation with the CCTG network, leadership, partners, patient representatives, and staff the new strategic direction for CCTG is unveiled.

“Together, we set down and shared our scientific priorities and supporting activities, captured feedback from our members, patients, and stakeholders and used it to ensure we address the opportunities ahead to conduct trials that will meaningfully improve outcomes for patients with cancer,” said CCTG Director, Dr. Janet Dancey.

Read More

Published:
Category: Office of the Director
Everyone has been touched by cancer either through their own journey or supporting a loved one. Despite better treatments and outcomes, the physical, emotional, and economic burden on patients, their families, and caregivers is likely to increase due to an aging population. In addition, the environment in which trials are conducted is becoming more complex. New therapies, biomarkers, and patient reported outcomes are changing the design, the type of data and the requirements for trial conduct and oversight. Read More



Published:
Category: Publications
CCTG trials that were featured at the American Society of Clinical Oncology General Meeting 2022 June 3-7, 2022 – McCormick Place, Chicago Read More

Published:
Category: Trials

The HE1 study, "Phase III Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases" has closed to accrual. 

Read More

Published:
Category: Trials
Trial closure notification for IND235, CO26 and MAC13. Read More